Literature DB >> 24158677

Tumorsphere assay provides more accurate prediction of in vivo responses to chemotherapeutics.

Soyoung Kim1, Caroline M Alexander.   

Abstract

Although the sphere culture system has been widely used in stem cell biology, its application for drug screening is limited due to lack of standardized, rapid analytical tools. To optimize sphere cultures for in vitro screening of drugs, we evaluated the properties of primary tumor cells growing as tumorspheres and compared their chemosensitivity to those of cells growing in monolayer. Most cells in tumorsphere cultures were quiescent whereas cells in monolayer culture had a high mitotic index. Moreover, doxorubicin showed better cytotoxicity than paclitaxel in the sphere cultures, but their efficacy was reversed in the monolayer cultures. Importantly, the response of cytotoxic outcomes for suspension cultures matched the in vivo response better than monolayer cultures, providing support for the use of short term suspension cultures of primary cells as a model for drug testing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24158677      PMCID: PMC3966961          DOI: 10.1007/s10529-013-1393-1

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  23 in total

1.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Wissam M Abdallah; Jessica M Foley; Kyle W Jackson; Michael F Clarke; Mari J Kawamura; Max S Wicha
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

2.  Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer.

Authors:  Bruce G Haffty; Qifeng Yang; Michael Reiss; Thomas Kearney; Susan A Higgins; Joanne Weidhaas; Lyndsay Harris; Willam Hait; Deborah Toppmeyer
Journal:  J Clin Oncol       Date:  2006-11-20       Impact factor: 44.544

3.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system.

Authors:  B A Reynolds; S Weiss
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

4.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

Review 5.  Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization.

Authors:  Virginia Tirino; Vincenzo Desiderio; Francesca Paino; Alfredo De Rosa; Federica Papaccio; Marcella La Noce; Luigi Laino; Francesco De Francesco; Gianpaolo Papaccio
Journal:  FASEB J       Date:  2012-09-28       Impact factor: 5.191

6.  Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

Authors:  George W Sledge; Donna Neuberg; Patricia Bernardo; James N Ingle; Silvana Martino; Eric K Rowinsky; William C Wood
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

Review 7.  Molecular effects of paclitaxel: myths and reality (a critical review).

Authors:  M V Blagosklonny; T Fojo
Journal:  Int J Cancer       Date:  1999-10-08       Impact factor: 7.396

8.  Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.

Authors:  Roman Rouzier; Radhika Rajan; Peter Wagner; Kenneth R Hess; David L Gold; James Stec; Mark Ayers; Jeffrey S Ross; Peter Zhang; Thomas A Buchholz; Henry Kuerer; Marjorie Green; Banu Arun; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-24       Impact factor: 11.205

Review 9.  Integrins, oncogenes, and anchorage independence.

Authors:  M A Schwartz
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

10.  Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways.

Authors:  Gillian Farnie; Robert B Clarke; Katherine Spence; Natasha Pinnock; Keith Brennan; Neil G Anderson; Nigel J Bundred
Journal:  J Natl Cancer Inst       Date:  2007-04-18       Impact factor: 13.506

View more
  13 in total

1.  Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERα+ Mammary Carcinomas.

Authors:  Michael P Shea; Kathleen A O'Leary; Saja A Fakhraldeen; Vincent Goffin; Andreas Friedl; Kari B Wisinski; Caroline M Alexander; Linda A Schuler
Journal:  Cancer Res       Date:  2018-01-23       Impact factor: 12.701

2.  IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.

Authors:  Lauren M Rota; Lidia Albanito; Marcus E Shin; Corey L Goyeneche; Sain Shushanov; Emily J Gallagher; Derek LeRoith; Deborah A Lazzarino; Teresa L Wood
Journal:  Cancer Res       Date:  2014-08-04       Impact factor: 12.701

3.  High collagen density augments mTOR-dependent cancer stem cells in ERα+ mammary carcinomas, and increases mTOR-independent lung metastases.

Authors:  Michael P Shea; Kathleen A O'Leary; Kyle A Wegner; Chad M Vezina; Linda A Schuler
Journal:  Cancer Lett       Date:  2018-06-20       Impact factor: 8.679

4.  Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy--the SpheroNEO study.

Authors:  Kathrin Halfter; Nina Ditsch; Hans-Christian Kolberg; Holger Fischer; Tanja Hauzenberger; Franz Edler von Koch; Ingo Bauerfeind; Gunter von Minckwitz; Ilona Funke; Alexander Crispin; Barbara Mayer
Journal:  BMC Cancer       Date:  2015-07-15       Impact factor: 4.430

5.  Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population.

Authors:  Carmela Ciccarelli; Francesca Vulcano; Luisa Milazzo; Giovanni Luca Gravina; Francesco Marampon; Giampiero Macioce; Adele Giampaolo; Vincenzo Tombolini; Virginia Di Paolo; Hamisa Jane Hassan; Bianca Maria Zani
Journal:  Mol Cancer       Date:  2016-02-20       Impact factor: 27.401

6.  17β-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct Outcomes.

Authors:  Fatou Jallow; Jennifer L Brockman; Kyle T Helzer; Debra E Rugowski; Vincent Goffin; Elaine T Alarid; Linda A Schuler
Journal:  J Endocr Soc       Date:  2018-02-26

7.  Ovatodiolide Inhibits Breast Cancer Stem/Progenitor Cells through SMURF2-Mediated Downregulation of Hsp27.

Authors:  Kuan-Ta Lu; Bing-Yen Wang; Wan-Yu Chi; Ju Chang-Chien; Jiann-Jou Yang; Hsueh-Te Lee; Yew-Min Tzeng; Wen-Wei Chang
Journal:  Toxins (Basel)       Date:  2016-04-28       Impact factor: 4.546

Review 8.  Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs.

Authors:  Che-Hsin Lee; Cheng-Chia Yu; Bing-Yen Wang; Wen-Wei Chang
Journal:  Oncotarget       Date:  2016-01-12

9.  High-Throughput Method for Automated Colony and Cell Counting by Digital Image Analysis Based on Edge Detection.

Authors:  Priya Choudhry
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

10.  ESE-1/ELF3 mRNA expression associates with poor survival outcomes in HER2+ breast cancer patients and is critical for tumorigenesis in HER2+ breast cancer cells.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.